Text Search

Theme Search

  • 1
  • 2
  • 3
  • 4

Sanfilippo syndrome

Search for glossary terms (regular expression allowed)
Begin with Contains Exact termSounds like
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Term Definition
Sanfilippo syndrome

MPS III is a mucopolysaccharide disease and is also known respectively as Sanfilippo syndrome.

It takes its name from Dr. Sylvester Sanfilippo who was one of the doctors in the United States who described the condition in 1963. Mucopolysaccharides are long chains of sugar molecule used in the building of connective tissues in the body. There is a continuous process in the body of replacing used materials and breaking them down for disposal. Children with MPS III are missing an enzyme which is essential in breaking down the used mucopolysaccharides called heparan sulfate. The incomplete broken down mucopolysaccharides remain stored in cells in the body causing progressive damage. To date, four different enzyme deficiencies have been found to cause MPS III, described as type A, B, C, or D.

Definition from National MPS Society website: Sanfilippo syndrome

Tell us your story

We are always looking for new stories to add to this site, and are particularly keen to hear from more practitioners. Your colleagues can learn so much from how you’ve dealt with situations which involved genetics.

Contact Us

Tell us what you think

Your feedback is important in helping us to enhance this website. Please take a moment to complete the brief questionnaire.


Winners of the Association of Healthcare Communicators Best use of new media award 2009.
‘This was superb’ - Judge’s comment.


Betsi Cadwaladr Scholarship Foundation Joint Award Winners 2013.

Betsi Cadwaladr logo